1037840-79-1

Basic information

• Product Name: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester
• Synonyms: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester;Methyl 5-bromo-1H-indazole-4-carboxylate;5-Bromo-1h-indazole-4-carboxylic acid,methyl ester
• CAS NO: 1037840-79-1
• Molecular Formula: C9H7BrN2O2
• Molecular Weight: 255.06808
• Mol File: 1037840-79-1.mol

Chemical Properties

• Boiling Point: 391.9±22.0 °C(Predicted)
• Appearance: /
• Density: 1.709±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 11.17±0.40(Predicted)
• CAS DataBase Reference: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester(1037840-79-1)
• EPA Substance Registry System: 1H-Indazole-4-carboxylic acid, 5-broMo-, Methyl ester(1037840-79-1)

Safety Data

• Hazardous Substances Data: 1037840-79-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1H-Indazole-4-carboxylic acid, 5-bromo-, methyl ester is utilized as a key intermediate in the synthesis of pharmaceutical compounds for its unique reactivity and structural properties. The presence of the bromine atom allows for further functionalization and modification, which can be crucial in the development of new drugs with specific therapeutic targets.
Used in Biochemical Research:
In the field of biochemical research, 1H-Indazole-4-carboxylic acid, 5-bromo-, methyl ester serves as a valuable tool for studying the interactions and mechanisms of various biological systems. Its unique structure can be employed to probe and understand complex biochemical processes, potentially leading to the discovery of novel therapeutic agents or insights into disease mechanisms.
Used in Organic Synthesis:
1H-Indazole-4-carboxylic acid, 5-bromo-, methyl ester is also used as a building block in organic synthesis, where its reactivity and properties can be harnessed to create a wide range of organic compounds. This versatility makes it an important compound in the development of new materials, agrochemicals, and other specialty chemicals.
Overall, 1H-Indazole-4-carboxylic acid, 5-bromo-, methyl ester is a multifaceted chemical compound with a broad spectrum of applications across various industries, particularly in pharmaceutical and biochemical research, where its unique properties and reactivity contribute to the advancement of scientific knowledge and the development of innovative solutions.

Upstream product

• 18583-89-6 methyl 3-amino-2-methylbenzoate 
• 750586-06-2 methyl 3-amino-6-bromo-2-methylbenzoate 

Relevant articles and documents

Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist

To develop potent and orally bioavailable melatonin receptor (MT1 and MT2) agonists, a novel series of 5-6-5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5,4-d][1,3]oxazole, cyclopenta[c]pyrazolo[1,5-a]pyridine, i

HETEROCYCLIC COMPOUND

Provided is a heterocyclic compound that can have an antagonistic action on an NMDA receptor containing the NR2B subunit, and is expected to be useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, periphera

BICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF

The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group optionally having substituent(s); R2 is a hydrogen atom or a hydrocarbon group optionally having substituent(s); Xa and Xb are each C, N, O or S; Xc and Xd are each C or N; m is 0-2; n is 1-3; ring A is a 5-membered ring optionally having substituent(s); ring B is a 6-membered ring optionally having substituent(s); and ring C is a 3- to 5-membered ring optionally having substituent(s), provided that when Xa, Xc and Xd are each C, then Xb is N or S, or a salt thereof, which is useful as an agent for the prophylaxis or treatment of a disease relating to an action of melatonin, and the like.

TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF

The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group opt